Castle Biosciences Inc
Castle Biosciences Inc (CSTL) Options Open Interest
CSTL options open interest is 410 contracts. The 2-week average daily volume is 5 contracts across the chain.
Read more
Monitoring CSTL open interest helps you see where real money is positioned on Castle Biosciences Inc's options and which strikes are attracting the most commitment from traders. Castle Biosciences Inc's open interest reflects the total number of outstanding contracts that have not been closed or exercised, making it a powerful gauge of liquidity, conviction, and potential support and resistance zones. Use our scanner to monitor CSTL options open interest in real time and find the strikes that matter.
Open interest is distinct from volume: volume counts how many contracts are traded in a session, while open interest counts how many remain open at the end of the day. Rising CSTL options open interest alongside rising volume suggests new positions are being built, while falling open interest signals positions are being closed. Heavy open interest at specific strikes often acts as a magnet near expiration and can hint at where dealers and large traders expect Castle Biosciences Inc to settle.
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company also offers DecisionDx-UM test, a proprietary GEP test that predicts the risk of metastasis for patients with uveal melanoma, a rare eye cancer; DecisionDx-SCC, a proprietary 40-gene expression profile test that uses an individual patient's tumor biology to predict individual risk of squamous cell carcinoma metastasis for patients with one or more risk factors; and DecisionDx DiffDx-Melanoma and myPath Melanoma, a proprietary GEP test to diagnose suspicious pigmented lesions.
It offers test services through physicians and their patients. The company was founded in 2007 and is headquartered in Friendswood, Texas.
Pin risk into expiration, dealer positioning, liquidity checks for large orders — all of it starts with knowing where CSTL open interest is concentrated. Our scanner maps Castle Biosciences Inc's open interest across every strike and expiry, flags unusual buildups, and lets you drill into the contracts that institutional money is actually holding. Trade Castle Biosciences Inc's options open interest as the signal it is, not as an afterthought.
| 40.00 | — | 0.75 | 0.75 | 66% | +0.2362 | 208 |
| 30.00 | 3.60 | 7.50 | 5.55 | 70% | +0.8279 | 26 |
| 15.00 | 18.10 | 21.90 | 20.00 | 175% | +0.9830 | 15 |
| 35.00 | 0.80 | 3.00 | 1.90 | 54% | +0.5228 | 11 |
| 25.00 | 8.10 | 11.60 | 9.85 | 15% | +1.0000 | 7 |
| 20.00 | — | 0.55 | 0.55 | 172% | -0.0680 | 24 |
| 15.00 | — | 0.75 | 0.75 | 265% | -0.0561 | 10 |
| 25.00 | — | 0.75 | 0.75 | 128% | -0.1167 | 3 |
| 30.00 | — | 1.20 | 1.20 | 93% | -0.2232 | 3 |
| 5.00 | — | 0.05 | 0.05 | 344% | -0.0040 | 0 |
As of September 22, 2026
Follow the money
Track CSTL open interest across every strike and expiration, identify where conviction is building, and trade with the positioning data on your side.
Start your 14-day free trial→